I previously mentioned in a blog that litigation was ongoing involving the use of baby powder, a product made from the mineral talc, for purposes of feminine hygiene. The allegation is that frequent use of baby powder is linked to ovarian cancer. An overview of the status of that litigation appeared in the Houston Chronicle’s on September 27th, 2016 in an article written by Linda Johnson of the Associated Press.
According to the article, the maker of the powder, Johnson & Johnson, contends there is no scientifically proven link between the product and ovarian cancer and intends to take every case to trial rather than settle. There are over 2,000 cases pending.
On the other hand, lawyers for the claimants continue to believe there is scientifically reliable research establishing a link. Another case went to trial on Monday, September 26, 2016, in St. Louis. This year, a jury in St. Louis found Johnson & Johnson liable to two women and awarded $72,000,000 and $55,000,000.
The legal battle revolves around the question of whether scientific evidence relied upon by the claimants is sufficient to meet the strenuous legal tests now applied to the admissibility of all scientific evidence.